AU Stock MarketDetailed Quotes

ZLDDG Zelira Therapeutics Ltd

Watchlist

0.000
0.0000.00%

20min DelayNot Open Mar 11 10:00 AET

0Market Cap0.00P/E (Static)

Zelira Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2021

(FY)Jun 30, 2020

(FY)Jun 30, 2019

Total revenue

432.57K

Operating revenue

--432.57K

----

----

Cost of revenue

228.22K

Gross profit

204.35K

Operating expense

28.46%10.2M

87.26%7.94M

4.24M

Selling and administrative expenses

127.51%4.49M

57.57%1.97M

--1.25M

-General and administrative expense

127.51%4.49M

57.57%1.97M

--1.25M

Research and development costs

--2.08M

----

----

Depreciation amortization depletion

72.42%474.26K

--275.05K

----

-Depreciation and amortization

72.42%474.26K

--275.05K

----

Other operating expenses

-44.63%3.15M

90.50%5.69M

--2.99M

Operating profit

-25.88%-9.99M

-87.26%-7.94M

-4.24M

Net non-operating interest income (expenses)

-1,019.53%-41.9K

-104.15%-3.74K

90.14K

Non-operating interest income

-91.59%723

-90.46%8.6K

--90.14K

Non-operating interest expense

245.33%42.63K

--12.34K

----

Other net income (expenses)

60.35%1.48M

59.45%925.49K

580.44K

Other non-operating income (expenses)

60.35%1.48M

59.45%925.49K

--580.44K

Income before tax

-21.87%-8.55M

-96.62%-7.02M

-3.57M

Income tax

0

0

0

Earnings from equity interest net of tax

Net income

-21.87%-8.55M

-96.62%-7.02M

-3.57M

Net income continuous operations

-21.87%-8.55M

-96.62%-7.02M

---3.57M

Noncontrolling interests

Net income attributable to the company

-21.87%-8.55M

-96.62%-7.02M

-3.57M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-21.87%-8.55M

-96.62%-7.02M

-3.57M

Diluted earnings per share

12.05%-1.2776

-76.60%-1.4526

-0.8225

Basic earnings per share

12.05%-1.2776

-76.60%-1.4526

-0.8225

Dividend per share

Accounting Standards

US-GAAP

US-GAAP

US-GAAP

	(FY)Jun 30, 2021	(FY)Jun 30, 2020	(FY)Jun 30, 2019
Total revenue	432.57K
Operating revenue	--432.57K	----	----
Cost of revenue	228.22K
Gross profit	204.35K
Operating expense	28.46%10.2M	87.26%7.94M	4.24M
Selling and administrative expenses	127.51%4.49M	57.57%1.97M	--1.25M
-General and administrative expense	127.51%4.49M	57.57%1.97M	--1.25M
Research and development costs	--2.08M	----	----
Depreciation amortization depletion	72.42%474.26K	--275.05K	----
-Depreciation and amortization	72.42%474.26K	--275.05K	----
Other operating expenses	-44.63%3.15M	90.50%5.69M	--2.99M
Operating profit	-25.88%-9.99M	-87.26%-7.94M	-4.24M
Net non-operating interest income (expenses)	-1,019.53%-41.9K	-104.15%-3.74K	90.14K
Non-operating interest income	-91.59%723	-90.46%8.6K	--90.14K
Non-operating interest expense	245.33%42.63K	--12.34K	----
Other net income (expenses)	60.35%1.48M	59.45%925.49K	580.44K
Other non-operating income (expenses)	60.35%1.48M	59.45%925.49K	--580.44K
Income before tax	-21.87%-8.55M	-96.62%-7.02M	-3.57M
Income tax	0	0	0
Earnings from equity interest net of tax
Net income	-21.87%-8.55M	-96.62%-7.02M	-3.57M
Net income continuous operations	-21.87%-8.55M	-96.62%-7.02M	---3.57M
Noncontrolling interests
Net income attributable to the company	-21.87%-8.55M	-96.62%-7.02M	-3.57M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	-21.87%-8.55M	-96.62%-7.02M	-3.57M
Diluted earnings per share	12.05%-1.2776	-76.60%-1.4526	-0.8225
Basic earnings per share	12.05%-1.2776	-76.60%-1.4526	-0.8225
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP